Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Azithromycin in the treatment of COVID-19: a review
Daniel Echeverría-Esnal, Clara Martín‐Ontiyuelo, María Eugenia Navarrete-Rouco, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 2, pp. 147-163
Open Access | Times Cited: 233

Showing 1-25 of 233 citing articles:

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, et al.
The Lancet (2021) Vol. 397, Iss. 10274, pp. 605-612
Open Access | Times Cited: 531
COVID-19: Characteristics and Therapeutics
Rameswari Chilamakuri, Saurabh Agarwal
Cells (2021) Vol. 10, Iss. 2, pp. 206-206
Open Access | Times Cited: 259
Pharmaceutical compounds used in the COVID-19 pandemic: A review of their presence in water and treatment techniques for their elimination
Carlos Augusto Morales-Paredes, Joan Manuel Rodríguez-Díaz, Nuria Boluda Botella
The Science of The Total Environment (2021) Vol. 814, pp. 152691-152691
Open Access | Times Cited: 151
Antimicrobial Resistance in the Context of the Sustainable Development Goals: A Brief Review
Márió Gajdács, Edit Urbán, Anette Stájer, et al.
European Journal of Investigation in Health Psychology and Education (2021) Vol. 11, Iss. 1, pp. 71-82
Open Access | Times Cited: 124
The use of antibiotics in COVID-19 management: a rapid review of national treatment guidelines in 10 African countries
Yusuff Adebayo Adebisi, Nafisat Dasola Jimoh, Isaac Olushola Ogunkola, et al.
Tropical Medicine and Health (2021) Vol. 49, Iss. 1
Open Access | Times Cited: 112
A Global Picture: Therapeutic Perspectives for COVID-19
Vivek P. Chavda, Carron Kapadia, Shailvi Soni, et al.
Immunotherapy (2022) Vol. 14, Iss. 5, pp. 351-371
Open Access | Times Cited: 71
An overview on the treatments and prevention against COVID-19
Yunes Panahi, Armita Mahdavi Gorabi, Sona Talaei, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 48
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
Jorge Calderón‐Parra, A. Muiño-Míguez, Alejandro David Bendala Estrada, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251340-e0251340
Open Access | Times Cited: 99
What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?
Richard G. Wamai, Jason L. Hirsch, Wim Van Damme, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 16, pp. 8638-8638
Open Access | Times Cited: 73
The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment
Yifei Wang, Jingbin Zheng, Md Sahidul Islam, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1507-1520
Open Access | Times Cited: 66
Autophagy in health and disease: From molecular mechanisms to therapeutic target
Guang Lu, Yu Wang, Yin Shi, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 62
Self-Medication Practices in Medical Students During the COVID-19 Pandemic: A Cross-Sectional Analysis
Farah Yasmin, Muhammad Sohaib Asghar, Unaiza Naeem, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 52
COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies
Domenico Iacopetta, Jessica Ceramella, Alessia Catalano, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 573-573
Open Access | Times Cited: 49
Review on PLGA Polymer Based Nanoparticles with Antimicrobial Properties and Their Application in Various Medical Conditions or Infections
Ashok K. Shakya, Mazen Al-Sulaibi, Rajashri R. Naik, et al.
Polymers (2023) Vol. 15, Iss. 17, pp. 3597-3597
Open Access | Times Cited: 28
Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 2, pp. 77-83
Open Access | Times Cited: 22
A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID‐19 patients
Carlo Brogna, Luigi Montano, Maria Elisabetta Zanolin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 3
Open Access | Times Cited: 9
Magnetic dispersive solid-phase extraction of clarithromycin and azithromycin by Fe3O4@ionic salt g-C3N4 adsorbent and HPLC-UV
Seyedeh Susan Sayyedi, Tahere Khezeli, Ali Daneshfar
Microchemical Journal (2024) Vol. 203, pp. 110868-110868
Closed Access | Times Cited: 7
Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital
Alice Ramos Oliveira Silva, Diamantino Salgado, Luís Phillipe Nagem Lopes, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43
Therapeutic Effectiveness and Safety of Repurposing Drugs for the Treatment of COVID-19: Position Standing in 2021
Safaet Alam, Taslima Binte Kamal, Md. Moklesur Rahman Sarker, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 42
Occurrence and distribution of azithromycin in wastewater treatment plants, seawater, and sediments of the northern part of the Persian Gulf around Bushehr port: A comparison with Pre-COVID 19 pandemic
Farzad Mirzaie, Fatemeh Teymori, Seyedehfatemeh Shahcheragh, et al.
Chemosphere (2022) Vol. 307, pp. 135996-135996
Open Access | Times Cited: 35
Azithromycin through the Lens of the COVID-19 Treatment
Georgia G. Kournoutou, George P. Dinos
Antibiotics (2022) Vol. 11, Iss. 8, pp. 1063-1063
Open Access | Times Cited: 33
Pathophysiology of Pulmonary Fibrosis in the Context of COVID-19 and Implications for Treatment: A Narrative Review
Son Duc Tran, Andre Ksajikian, Juliana Overbey, et al.
Cells (2022) Vol. 11, Iss. 16, pp. 2489-2489
Open Access | Times Cited: 32
Randomized controlled trial of favipiravir, hydroxychloroquine, and standard care in patients with mild/moderate COVID-19 disease
Manaf AlQahtani, Nitya Kumar, Dhuha Aljawder, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies
Elisa Souza Vaz, Sandra V. Vassiliades, Jeanine Giarolla, et al.
European Journal of Clinical Pharmacology (2023) Vol. 79, Iss. 6, pp. 723-751
Open Access | Times Cited: 16
Five greenness assessments of novel RP-UPLC and MCR methods for concurrent determination of selected pharmaceutical drugs in comparison with the lean Six Sigma approach
Tahani Y. A. Alanazi, Manal A. Almalki, Mahmoud A. Mohamed, et al.
Microchemical Journal (2023) Vol. 194, pp. 109359-109359
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top